High GRN expression has been detected in many types of cancer and elevated serum GRN levels could be used as a potential prognostic biomarker in for example breast cancer, chronic lymphocytic leukemia, and non-small-cell lung carcinoma (Arechavaleta-Velasco et al., 2017). Here, GRN is linked to cancer.